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ABSTRACT 
International Journal of Exercise Science 12(6): 412-424, 2019. This study examined effects of caffeine 
(CAF) on power output (PO) selection and associated physiological responses during cycling at moderate and high 
intensities prescribed by RPE (0-10 scale). Participants (n = 9) (VO2peak: 55.4 ± 6.32 mL · kg-1 · min-1) cycled for 
20 min at RPE4 and 20 min at RPE7 separated by 10 min recovery following caffeine (CAF) (6 mg · kg-1) and placebo 
(PLA) ingestion. PO, HR, serum lactate [La], VO2, VE, and RER were recorded every 5 min. Session RPE (S-RPE) 
was recorded following 10 min recovery. Repeated-measures ANOVA’s, 2 (trial) x 4 (time pt), showed significantly 
greater PO during RPE4 for CAF (130 ± 23 W) vs PLA (112 ± 26 W) and during RPE7 (CAF: 165 ± 37 vs PLA: 143 ± 
41 W). Overall HR, VO2, and VE were significantly greater for CAF vs PLA during RPE7. RER for RPE4 and RPE7 
were not significantly different (CAF vs PLA). Overall [La] was significantly greater for CAF during RPE4 (CAF: 
2.32 ± 0.94 vs PLA: 1.73 ± 1.09) and RPE7 (CAF: 3.22 ± 1.44 vs PLA: 2.22 ± 1.49). Paired T-tests for S-RPE revealed 
no significant difference for RPE4 (CAF: 4.0 ± 0.5 vs PLA: 3.7 ± 0.5) or RPE7 (CAF: 7.1 ± 0.3 vs PLA: 6.9 ± 0.6) despite 
greater PO for CAF. Although individual responses varied, the current study indicates caffeine ingestion results in 
elevated self-selected PO with significant systematic changes in associated physiological responses particularly at 
a higher intensity (RPE7). 
 




Ergogenic effects of caffeine have been well established in aerobic (26, 28, 30, 31) and anaerobic 
(4, 14, 20, 34, 36) exercise. A meta-analysis by Doherty and Smith (16) indicated caffeine ingestion 
prior to exercise improved performance by as much as 12% during endurance, graded, and 
short-term exercise tests. Although various dosages have been studied, oral consumption of 
anhydrous caffeine 1 hr prior to exercise has been shown effective at 6 mg·kg-1 body mass (6, 
13).  
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Mechanisms by which caffeine may exhibit ergogenic effects continue to be explored. A 
competitive blockade of adenosine A1 and/or A2 receptors has been proposed (24, 51, 55). Such 
a blockade in the central nervous system may lead to a decreased perception of pain during 
exercise (7, 14, 18, 45) resulting in greater effort, improved performance, and altered perceptual 
responses (RPE). Further, previous research has shown caffeine may alter RPE during exercise. 
RPE may be lower at a given workload following caffeine ingestion (6), or an effect can be 
demonstrated when RPE estimations are similar between trials when caffeine (vs placebo) 
results in completion of significantly more work (11, 37).  
 
Traditionally, RPE may be estimated by a participant during activity reflecting subjective 
feelings of exertion or as a method for prescription and regulation of intensity (i.e. RPE 
production) (1). RPE-based prescriptions have been validated for laboratory settings using the 
estimation-production paradigm (10, 19, 49, 50). With this approach, individuals estimate RPE 
during an incremental exercise trial and in subsequent training, effort is adjusted to self-regulate 
intensity producing a target RPE (9, 22, 38). Although inconsistencies exist, RPE generally is 
effective for prescribing and regulating intensity (23, 32, 33, 42, 52). Using the estimation-
production paradigm, measurement of VO2, lactate [La], heart rate (HR) or other objective 
physiological variables is not essential.   
 
The influence of caffeine on RPE based intensity regulation (i.e. estimation-production 
paradigm) is not well understood, as effort sense during exercise remains a complex 
phenomenon (18). Cole et al (11) examined the effects of a 6 mg·kg-1 caffeine dose on the self-
regulation of exercise intensity using three progressive RPE prescriptions. Participants 
performed a continuous 30 min cycling session subdivided into three 10 min bouts at prescribed 
RPE values (9, 12, and 15). Compared to placebo, caffeine resulted in significantly greater total 
work for the combined 30 min exercise (277.8 ± 26.1 kJ vs 246.7 ± 21.5 kJ). Interestingly, 
workloads within levels of RPE prescription were not significantly different following caffeine 
ingestion. The potential influence of caffeine ingestion on self-selected workloads during RPE 
production trials is unclear. The current study examined effects of 6 mg·kg-1 caffeine on self-






Male cyclists and runners were recruited (n = 9) as participants. Prior to data collection, 
participants completed a health screening questionnaire (PAR-Q) and a written, informed 
consent. Research was conducted in compliance with the guidelines and policies of the local 
Institutional Review Board for protection of human participants. During the initial lab session, 
descriptive data including age (yr), height (cm), and mass (kg) were collected using a standard 
stadiometer (Detecto, Webb City, MO) and a calibrated Tanita EWB-800 scale (Tokyo, Japan). 
Body fat percentage was estimated via 3-skinfold-site method (47) (chest, abdomen, thigh) using 
Lange calipers (Cambridge, MA). A daily caffeine exposure questionnaire was administered to 
assess typical ingestion. Participants reported to the lab for a total of three sessions. Session 1 
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included a maximal exertion test (VO2Peak) on a cycle ergometer (Monark 828E, Varberg, 
Sweden) and was separated from Session 2 by ≥ 48 hr. Sessions 2 and 3, caffeine (CAF) and 
placebo (PLA) sessions, were randomized, double-blind, and counterbalanced to control for 
ordering and separated by ≥ 24 hr. Time of testing for CAF and PLA was replicated for each trial 
within participants to limit effect of circadian rhythms on dependent measures. Participants 
were instructed to abstain from heavy exercise and caffeine use for ≥ 12 hr prior to each testing 




Prior to all testing, participants were fitted with an appropriately-sized air cushion mask 
(VacuMed, Ventura, CA) and HR monitor transmitter (T31 Transmitter, Polar Electro, Stamford, 
Kempele, Finland) before exercise. Metabolic data (VO2, VCO2, RER and VE) were assessed 
from expired air via an indirect open circuit spirometry system (Vacu-Med, Ventura, CA) 
equipped with Turbofit software (TurboFit, VacuMed, Ventura, CA). The system was calibrated 
prior to all metabolic testing using a gas of known concentration (16% O2, 4% CO2). Ventilatory 
measurement was calibrated using a 3-L syringe (Hans Rudolph, Kansas City, MO). A 1-10 RPE 
scale (50) was displayed in view of participants at all times. 
 
The Monark cycle ergometer was adjusted to individual preference for seat height and 
handlebar positioning. Participants were instructed to maintain 70 rev·min-1 throughout and 
began the exercise test at 35 Watts (W) for 3 min as a warm-up. Following the warm-up, 
resistance increased 70 W every 2 min until volitional exhaustion or failure of participant to 
maintain pedaling frequency for 10 s when provided verbal encouragement. Overall RPE (RPE-
O) was estimated by participants during the last 10 s of each minute. Metabolic data (20 s means) 
were reported during the last 10 s of each minute. 
 
Caffeine and placebo (maltodextrin) capsules matched for appearance were administered in 
sealed containers prior to each trial. Ingestion of capsules at the appropriate time (1 hr prior to 
testing) was verified verbally upon arrival. During exercise trials, two capillary blood samples 
were taken from the fingertip and immediately analyzed for serum lactate concentrations [La] 
(1500 Sport Lactate Analyzer, Yellow Springs Instruments, Yellow Springs, OH). The mean of 
the two samples recorded at each time point was used for analysis. Prior to each trial, the 
analyzer was calibrated using 5 mmol·L-1 standard and checked for linearity with 15 mmol·L-
1 standard as per manufacturer instructions.  
 
During production trials, participants were instructed to maintain a pedaling frequency of 70 
rev·min-1 with cadence displayed digitally on the ergometer. Throughout exercise, participants 
were allowed to adjust the resistance on the ergometer; however, the readout display was 
concealed so that participants had no knowledge of the selected workload or PO. Participants 
began with a 3 min warm-up at 35 W. Immediately following the warm-up, participants were 
allotted 3 min to adjust the resistance as needed to produce an RPE of 4 (RPE4) based on overall 
feelings of exertion. Following the 3 min production period, PO was recorded (time: 0 min) and 
participants completed 20 min of cycling. Participants were only allowed to change the 
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resistance every 5 min, but were instructed to maintain the prescribed RPE. After cycling 20 min, 
participants dismounted the ergometer and recovered passively for 10 min. Following the 10 
min recovery, participants estimated session RPE (S-RPE) and repeated the above protocol at a 
prescribed RPE of 7 (RPE7) based on overall feelings of exertion. At the completion of the RPE7 
production trial, participants again recovered passively for 10 min following exercise 
termination and provided a S-RPE. Blood samples were collected and analyzed for [La] as 
described above at 5, 10, 15, and 20 min for RPE4 and RPE7. Corresponding metabolic data (60 
s means) were also recorded at 5, 10, 15, and 20 min. HR was recorded continuously throughout 
each 20 min cycling trial (POLAR Team2 Pro, Polar Electro Oy, Kempele, Finland) and reported 
as 5 min means corresponding to [La] and metabolic data at 5, 10, 15 and 20 min. PO was 
recorded at 0, 5, 10, and 15 min with recording of physiological variables 5 min later per time 
point. This permitted a physiological steady state to be achieved which corresponded with the 
acute PO selection. 
 
Statistical Analysis 
All data were analyzed via SPSS software (Version 20). A series of repeated measures ANOVAs 
were used to assess differences with a principle focus on differences between treatments (CAF 
vs PLA). A 2 (trial) x 4 (time pt) repeated measures ANOVA was used for PO, HR, [La], VO2, 
RER, and VE with a principle focus on between trial differences at each time point. Tukey’s LSD 
(1 tailed p-values) was used as a follow-up test between trials. Paired sample t-tests were used 
to analyze differences in S-RPE for RPE4 and RPE7. Results were considered significant at p ≤ 
0.05. Based on the results of a similar study by Cole et al (11), a power analysis indicated that a 




Mean and standard deviation for VO2, HR, [La], RER, and VE between CAF and PLA are 
displayed in Table 2 (RPE4) and Table 3 (RPE7). A significant main effect for trial for VO2 was 
found for RPE7 (p = 0.01). Follow-up tests showed significantly greater values for CAF at 5, 10, 
15 and 20 min. The main effect for VO2 for RPE4 approached significance (p = 0.08). Follow-up 
tests showed significant differences at 5, 15 and 20 min. Main effect for trial for HR was 
significant for RPE7 (p = 0.03), but HR during RPE4 did not reach significance (p = 0.18). Follow-
up tests showed HR during RPE7 was significantly greater for CAF at 10, 15 and 20 min, while 
during RPE4 significant differences were found at 15 and 20 min. HR data for one participant 
during RPE4 trials were excluded due to equipment failure (n = 8). [La] was significantly greater 
for CAF vs PLA during both RPE4 (trial main effect, p = 0.03) and RPE7 (trial main effect, p = 
0.03). [La] for CAF was significantly greater for RPE4 at 5 and 20 min, while values for RPE7 
were significant at 10, 15 and 20 min and approached significance at 5 min (p = 0.057). For RPE4, 
VE approached significance (trial main effect, p = 0.07) with significance at 15 and 20 min. Within 
RPE7 trials, VE was significantly greater for CAF vs PLA (trial main effect, p = 0.03) with follow-
up tests showing significance at 5, 10, 15, and 20 min. RER was not significantly different 
between treatments for either RPE4 (p = 0.68) or RPE7 (p = 0.64). There were no significant 
differences found for S-RPE for RPE4 (CAF = 4.0 ± 0.5, PLA = 3.7 ± 0.5, p = 0.20) or RPE7 (CAF 
= 7.1 ± 0.3, PLA = 6.9 ± 0.6, p = 0.35). 
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Table 1. Descriptive characteristics for participants. 
Variable Mean SD 
Age (yrs) 28.2 6.5 
Ht (cm) 176.6 5.6 
Mass (kg) 74.3 7.2 
Body fat (%) 9.5 3.2 
VO2 peak (mL·kg-1·min-1) 55.4 6.3 
Mean daily caffeine consumption (mg) 257 174 
 
Follow-up tests showed significantly greater power selection at each time point for CAF for 
RPE4 (Figure 1) and RPE7 (Figure 2). 
  
Figure 1. PO CAF vs PLA over time for RPE4                 Figure 2. PO CAF vs PLA over time for RPE7     
(Mean ± SD). * p ≤ 0.05.                                                       (Mean ± SD). * p ≤ 0.05. 
Table 2. Physiological responses for CAF vs. PLA for RPE4 over time (Mean ±SD). 
 Trial 5 min 10 min 15 min 20 min 
VO2 (mL·kg-1·min-1) CAF   30.0 ± 5.0*   31.0 ± 4.7†   31.6 ± 4.5*   32.4 ± 5.2* 
PLA 25.1 ± 3.7 26.7 ± 5.8 27.6 ± 5.5 27.8 ± 6.3 
HR (b·min-1) CAF 132 ± 16 137 ± 18   141 ± 18†   144 ± 20* PLA 127 ± 13 128 ± 14 131 ± 14 132 ± 15 
[La] (mmol·L-1) CAF   2.44 ± 0.54* 2.16 ± 0.97   2.30 ± 1.23†   2.39 ± 1.31* PLA 1.78 ± 0.70 1.70 ± 1.24 1.67 ± 1.25 1.75 ± 1.30 
VE (L·min-1) 
CAF 43.8 ± 6.0   45.9 ± 6.8†   47.36 ± 5.7*   48.78 ± 7.8* 
PLA 39.2 ± 7.4 39.7 ± 7.5 41.03 ± 7.9 42.61 ± 8.8 
RER CAF 0.88 ± 0.06 0.87 ± 0.05 0.89 ± 0.05 0.88 ± 0.05 PLA 0.91 ± 0.09 0.89 ± 0.05 0.89 ± 0.05 0.91 ± 0.07 
* p ≤ 0.05 CAF vs PLA. † p = 0.09 CAF vs PLA. 
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Table 3. Physiological responses for CAF vs. PLA for RPE7 over time (Mean ± SD). 
 Trial 5 min 10 min 15 min 20 min 
VO2 (mL·kg-1·min-1) 
CAF   35.3 ± 5.2*   37.5 ± 5.3*   39.1 ± 5.6*   39.6 ± 4.6* 
PLA 29.8 ± 5.5 32.0 ± 4.9 33.9 ± 6.6 33.4 ± 7.7 
HR (b·min-1) CAF   145 ± 18†   154 ± 17*   160 ± 17*   164 ± 17* PLA 136 ± 19 140 ± 20 146 ± 20 150 ± 21 
[La] (mmol·L-1) CAF     2.55 ± 1.3**   2.90 ± 1.50*    3.46 ± 1.64*    3.96 ± 1.66* PLA 1.99 ± 1.4 2.02 ± 1.60  2.41 ± 1.71  2.45 ± 1.44 
VE (L·min-1) 
CAF     56.5 ± 12.3*   59.7 ± 9.4* 65.4 ± 9.7*   68.6 ± 10.4* 
PLA 45.1 ± 8.1 48.8 ± 8.6 54.0 ± 12.0 54.6 ± 12.6 
RER CAF 0.91 ± 0.07 0.93 ± 0.04 0.95 ± 0.05 0.95 ± 0.05 PLA 0.91 ± 0.06 0.91 ± 0.05 0.94 ± 0.06 0.93 ± 0.07 




Previous research indicates that caffeine attenuates estimated RPE, potentially associated with 
improved exercise performance (2, 16, 46). RPE may be mitigated when exercising at a given 
workload compared to placebo (7, 17, 41) or RPE may be similar (vs placebo) when greater 
amounts of work are performed (15, 37, 43). Both paradigms reflect an effect of caffeine on RPE. 
In regards to training, prescribing exercise utilizing RPE (RPE production) is well accepted (1, 
39). Advantages include convenience due to a decreased need for assessing objective measures 
such as HR, [La] or VO2. It is unclear if the mitigating effects of a moderate dose of caffeine 
persist when exercise intensity is prescribed and regulated using RPE. Therefore, this study 
examined effects of 6 mg·kg-1 caffeine (vs placebo) on workload selection and associated 
physiological responses following exercise intensity prescriptions of RPE 4 and 7.  
 
The main finding of the current study was that the ingestion of caffeine resulted in the self-
selection of significantly higher workloads across time during lower (RPE4) (Figure 1) and 
higher (RPE7) (Figure 2) intensity production trials. A similar study by Cole et al (11) reported 
caffeine did not result in a significant increase in mean work output during RPE production 
(RPE: 9, 12, and 15), but resulted in significantly higher accumulated work. It was suggested that 
the increase in work output following caffeine ingestion was not dependent upon the RPE level. 
In contrast, current results suggest caffeine significantly increased self-selected PO during both 
RPE4 (CAF: 130.0 ± 22.6 W, PLA: 111.6 ± 25.5 W) and RPE7 (CAF: 164.8 ± 37.0 W, PLA: 142.7 ± 
40.9 W). Although both studies showed a significant increase in total work, discrepancy between 
studies may be attributable to the protocol used for RPE prescription. Cole et al. (11) utilized a 
30 min cycling exercise protocol consisting of three progressive levels of RPE (10 min each). The 
current study used an introductory 3 min production period, during this period participants 
were able to closely ensure their individual workload pertaining to each RPE level (4 and 7) 
prior to a 20 min cycling trial. This may be a source of the discrepancy since individual PO was 
selected to the target RPE before data collection commenced. Therefore, for RPE production 
during cycling exercise preceded by caffeine ingestion, the production period duration and 
protocol may impact acute outcomes.  
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Caffeine is known to limit the binding of endogenous adenosine to adenosine receptors reducing 
adenosine’s natural suppression of arousal and inhibitory modulation of neuronal excitability 
(24, 51). Therefore, it is plausible that caffeine acted as an analgesic reducing afferent feedback 
of exercise-associated pain and discomfort during production trials in the current study, 
resulting in selection of greater workloads. That is, responses observed for PO appear to have 
been due to the requirement of a greater stimulus (i.e. higher workload) to yield the prescribed 
RPE. 
 
In the current study, participants were blinded to acute PO during production trials and 
intensity was regulated by gauging overall subjective feelings throughout twenty minute 
cycling bouts. During performance based paradigms (i.e. time-trials), caffeine has increased self-
selected intensities and improved exercise performance as participants were aware of the 
performance based nature of the test (8, 12, 15, 40). Contrary to the nature of those studies, the 
current paradigm did not guide participants with any performance-based incentives; instead 
participants were instructed to maintain the prescribed intensity (RPE 4 and 7) as in a daily bout 
of exercise training. Consistent selection of higher workloads may increase total workload 
performed during daily exercise, which could result in greater total caloric expenditure during 
exercise sessions and enhanced intensity-dependent training adaptations. 
 
Duncan et al. (21) reported that caffeine ingestion elevated subjective measures of participant 
readiness to invest both mental and physical effort after performing fatiguing tests and prior to 
exercise performance tasks. If this occurred in the current study, a caffeine-induced elevation in 
the motivational state of participants may have altered subjective feelings of intensity (18). In 
fact, 6 out of 9 participants selected a higher initial PO following caffeine compared to placebo 
ingestion. This may be an important consideration when caffeine consumption precedes RPE-
regulated exercise training. However, current participants were not asked to identify CAF and 
PLA treatments and no attempt was made to directly assess motivational status. Regardless, 
ingestion of caffeine resulted in ergogenic benefits plausibly attributable to an alteration in RPE-
workload congruence. Future research should more directly examine potential effects of caffeine 
on motivational status and performance during perceptually-regulated training.  
 
Table 2 shows consistently higher VO2, HR, and VE, values for CAF compared to PLA during 
RPE4. Failure to achieve overall statistical significance for these variables may have been due to 
the relatively low intensity associated with RPE4. At a lower intensity, there may be a relatively 
low volume of pain, discomfort and change in other factors believed to mediate RPE. That is, if 
altered pain is the mechanism of action for caffeine, it is reasonable that low intensity exercise 
(vs higher intensity) presents a weaker paradigm in which to observe a convincing effect. A 
liberal approach to conducting follow-up tests was taken in the interest of identifying an effect, 
if it exists. More specifically, follow-up tests were conducted at specific time points for 
physiological variables when main effects approached significance because PO values were 
significant. More research is warranted as follow-up analyses revealed significantly greater VO2 
values for CAF compared to PLA at 5, 15 and 20 min (Table 2).  
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Robertson et al (48) contended that HR may not be an important mediator of exertional 
perception, while ventilatory drive stands to be a potent and consciously monitored 
physiological mediator for respiratory-metabolic perceptual signals during dynamic exercise.  
Exertional perceptions during exercise may also be influenced by peripheral afferent input (48). 
In contention, Marcora et al (44) expressed that afferent feedback from locomotor and 
respiratory muscles lacked a significant contribution to RPE. Current results show significantly 
greater HR and VE (RPE7) for CAF vs PLA, while greater workloads were selected to maintain 
the prescribed RPE (Table 3). Therefore, HR and VE as physiological mediators of exertional 
perception may have been suppressed due to the effects of CAF, while peripheral afferent 
feedback may have been masked as CAF prompted the requirement of greater workloads 
during exercise to produce the prescribed RPE (Table 3). It is understood that RPE is not 
mediated by any single physiological or psychological variable and in the current study 
contributions from independent mediators could not be discerned. However, it would seem that 
during low intensity exercise following caffeine ingestion, peripheral afferent input from 
exercising muscles may serve as a more important mediator of RPE due to the lack of response 
from HR, VE, and VO2. Further, mediators of RPE appear to be less distinguished during a 
moderate (vs higher) exercise intensity. More work is warranted to extend the knowledge in this 
regard. 
 
It was hypothesized that any significant increases in self-selected PO would subsequently elicit 
a response in [La]. Overall [La] during RPE4 was significantly greater for CAF vs PLA (Table 2), 
which concurs with other studies investigating the ergogenic effects of caffeine (5, 6, 40, 54). 
However, selection of greater workloads for CAF at RPE4 was only associated with significantly 
higher [La] for CAF vs PLA at 5 and 20 min (Table 2). [La] measurements for RPE7 (Table 3) 
were significantly greater for CAF compared to PLA with follow-up analyses showing 
significance at 10, 15 and 20 min, while approaching significance at 5 min (p = 0.057). In 
comparison to the lower intensity (RPE4), CAF manifested a greater effect at the higher intensity 
(RPE7) as [La] remained significantly elevated following the selection of higher power outputs. 
Future research should attempt to examine whether caffeine acted peripherally or centrally to 
affect metabolic changes or muscle recruitment. 
 
While caffeine’s influence on free fatty acids (FFA) mobilization have been debated, the 
observed RER values were not expressive of a turbulent shift to fat utilization during either 
RPE4 (Table 2) or RPE7 (Table 3) trials. Previous research has shown caffeine to function as an 
ergogenic aid by extending time to fatigue with benefits attributed to enhanced FFA 
concentration (3, 37, 53). However, enhanced performance has been observed in absence of 
increased FFA (27, 29, 35) indicating benefits of caffeine do not solely rest on altered substrate 
availability. In the current paradigm, RER values were either similar or lower for CAF versus 
PLA (Tables 2 and 3) even though PO was greater for CAF. This suggests a possible increased 
reliance on fat utilization, however, direct measures of blood FFA were not assessed.  
 
S-RPE involves subjective estimation of effort pertaining to the global difficulty of an entire 
exercise session. S-RPE estimation following exercise serves as a model for monitoring training 
responses and preventing the possible adverse effects of overtraining (25). Caffeine ingestion 
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has been shown to attenuate S-RPE even when total work volume is equated between caffeine 
and placebo trials (41). Current results revealed no significant difference for S-RPE (CAF vs PLA) 
for RPE4 (Table 2) or RPE7 (Table 3). Different from the constant-load exercise protocol with 
equated total work volume in Killen et al (41), during the current study RPE remained constant 
between CAF and PLA conditions yet selection of PO was greater for CAF (vs PLA). Therefore, 
the similar S-RPE (CAF vs PLA) observed with concurrent higher PO indicates caffeine also 
altered S-RPE. A systematic increase would have been expected for S-RPE yet this was not 
observed. Consequently, current results confirm those of Killen et al. (41) that caffeine alters S-
RPE responses.   
 
A practical difference in PO was assumed to be a mean difference ≥ 20 W. Using this criterion, 
3 participants were identified as non-responders and 2 as negative responders for RPE4. For 
RPE7, 3 participants were identified as non-responders. This observation supports the notion 
that individual responses vary. Following the removal of non-responders, the relative intensity 
based on %VO2Peak for each individual was calculated. Figure 3 and Figure 4 display calculated 
data (Mean ± SD) of responders for achieved percent relative VO2Peak (%VO2Peak) compared 
between CAF and PLA for RPE4 and RPE7, respectively. At RPE4, responders exercised at a 
mean %VO2Peak at least 15% greater during CAF than PLA. At RPE7, mean %VO2Peak for 
responders was at least 13% greater (CAF vs PLA). Assessment of individual results is important 
to ascertain the true impact of caffeine. From a statistical standpoint, those who fail to respond 
for whatever reason will alter the overall aggregate results and thus attenuate the magnitude of 
the impact for those who do respond. Further work is needed to determine the precise reasons 






Figure. 3 Mean relative % VO2Peak 
CAF vs PLA over time for RPE4 
for responders only (n = 4). 
 
Figure 4. Mean relative % VO2Peak 
CAF vs PLA over time for RPE7 
for responders only (n = 6). 
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RPE production is a validated and useful method for prescribing exercise that does not require 
monitoring of physiological variables such as HR. The results of this study show that a moderate 
dose of caffeine ingested 1 hr prior to exercise may alter an individual’s perception of effort 
sequentially increasing total work during cycling exercise. Based on the current RPE-production 
paradigm, individuals ingesting caffeine prior to exercise may benefit from increased total work 
performed without a noticeable increase in perception of effort. Future research should more 
directly examine potential effects of caffeine on motivational status and performance during 
perceptually-regulated training. Although individual variation exists, it should be noted that 
RPE-based exercise prescription may be affected by caffeine consumption. 
 
Current results indicate caffeine ingestion (6 mg·kg-1) resulted in an increase in PO selection 
during RPE-based exercise prescription. Associated physiological variables also changed 
concomitant with elevated PO. While direct mechanisms associated with the observed 
differences are not clear, results have implications with regard to RPE-based exercise 
prescriptions. Although the RPE production paradigm is useful, efficacy following the ingestion 
of an ergogenic aid such as caffeine is not well understood. Understanding the link between 
perceptual responses and caffeine is important due to the increasing utilization of caffeine as an 
ergogenic aid prior to or during exercise. Notable variations in responses among participants 
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